MYRON S. COHEN, MD, FIDSA, an internationally recognized leader in HIV prevention, is one of two recipients of IDSA’s 2012 Society Citation. First awarded in 1977, this is a discretionary award given in recognition of exemplary contribution to IDSA, an outstanding discovery in the field of infectious diseases, or a lifetime of outstanding achievement. Dr. Cohen meets the criteria in every respect, having volunteered time and energy to IDSA, and having made enormous contributions to our understanding of the transmission of HIV, and the synergy between HIV treatment and prevention.
Dr. Cohen led the groundbreaking HIV Prevention Trials Network (HPTN) 052 clinical trial—a herculean effort that began in 2000 with trial sites in the Americas, Asia, and Africa. The stunning and game-changing results of the study were made public last year: early treatment of the HIV-infected partner in a discordant couple reduced the risk of HIV transmission 96 percent while providing significant clinical benefits to the infected patient. This finding—named by the journal Science as the top scientific breakthrough of 2011—has already profoundly changed the policy discussions and program implementation plans in settings as diverse as New York City and Swaziland. After decades of debate about whether the AIDS response should prioritize treatment or prevention, Dr. Cohen and his colleagues have proven that treatment is prevention, and that treatment is lifesaving not only for individuals living with HIV infection, but also for their partners.
Dr. Cohen has recently assumed the position of co-chair of the HIV Prevention Trials Network (HPTN), along with fellow IDSA member Wafaa El-Sadr, MD, MPH, MPA, FIDSA, overseeing numerous other studies that are seeking to implement and scale-up the findings of HPTN 052, and test other HIV prevention interventions in combination. He has served on the scientific advisory committee of the IDSA/HIVMA Center for Global Health Policy and as a faculty member at this year’s inaugural research conference for IDSA fellows. Dr. Cohen also serves on the Scientific Advisory Committee for the Office of the Global AIDS Coordinator within the U.S. Department of State, and on the National Institutes of Health Office of AIDS Research Advisory Committee.
Dr. Cohen is the J. Herbert Bates Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology at the University of North Carolina (UNC) at Chapel Hill. He has served as chief of infectious diseases at UNC since 1990 and as director of the UNC Institute for Global Health and Infectious Diseases since 2007.
Dr. Cohen earned a medical degree from Rush Medical College in 1974, had an internship and residency at University of Michigan, and was an infectious diseases fellow at Yale University from 1977 to 1980. Colleagues recognize Dr. Cohen as an outstanding leader with immense breadth and depth of expertise, and as a tireless advocate for science-based policy. For his efforts, which have revolutionized the field of HIV prevention, IDSA is honored to present Dr. Cohen with a 2012 Society Citation.
N. CARY ENGLEBERG, MD, FIDSA, who led the process to create and maintain the IDSA Fellows In-Training Exam, is one of the recipients of IDSA’s 2012 Society Citation. First awarded in 1977, this is a discretionary award given in recognition of exemplary contribution to IDSA, or other outstanding discoveries or achievements.
Dr. Engleberg established the vision to create an in-training exam so fellows could gauge their medical knowledge, including strengths and weaknesses, in order to better prepare themselves for the infectious diseases examination of the American Board of Internal Medicine (ABIM). To meet this end, Dr. Engleberg contributed countless hours of his time organizing other volunteers and working with the National Board of Medical Examiners. Dr. Engleberg has demonstrated that fellows’ scores correlate with their performance on the boards, giving them an important perspective and feedback on their fund of medical knowledge. This work is also very helpful to program directors, enabling them to target deficient areas of medical knowledge more accurately.
More than 500 fellows took the first IDSA exam in 2008; it continues to grow steadily, with more than 95 percent of ID training programs in the United States having registered for the exam. In 2012, more than 750 fellows from more than 150 training programs in the United States and 15 training programs in eight other countries took the test. The exam has become a strong inducement for international membership recruitment for IDSA; program directors from training programs worldwide are now attending IDSA meetings.
Dr. Engleberg has been a professor of internal medicine and microbiology and immunology at the University of Michigan Medical School since 1997. He earned a medical degree from George Washington University in 1974 and a diploma in Tropical Medicine and Hygiene from London School of Hygiene and Tropical Medicine in 1980. He was an intern and resident in medicine at George Washington University Medical Center from 1974 to 1977; was an Epidemic Intelligence Service Officer in the Enteric Diseases Branch for the Bacterial Diseases Division of the Centers for Disease Control and Prevention; and was senior surgeon for the U.S. Public Health Service, Phoenix Area Indian Health Service, from 1980 through 1982. Dr. Engleberg was a fellow in infectious disease at the University of Texas Health Science Center at San Antonio, from 1982 to 1984.
Dr. Engleberg has served on various editorial boards. He has received numerous awards, including the Medical Student Award for Teaching Excellence (2004), the University of Michigan Departmental Award for Innovation in Teaching (2007), and the University of Michigan Lifetime Achievement Award in Medical Education (2011). He has published almost 70 peer-reviewed articles.
For his contributions to the education of infectious diseases fellows and his tireless commitment to the Society, IDSA is proud to honor Dr. Engleberg with a 2012 Society Citation.
ALAN D. TICE, MD, FIDSA, FSHEA, who helped organize the first IDSA clinical conference in 1990 and authored both of the IDSA Outpatient Parenteral Antimicrobial Therapy (OPAT) guidelines, is one of the recipients of IDSA’s Society Citation. First awarded in 1977, this is a discretionary award given in recognition of exemplary contribution to IDSA, or other outstanding discoveries or achievements.
During his years on the Clinical Affairs Committee, Dr. Tice represented IDSA in developing the Harvard Resource-Based Relative Value Scale and testified before Congress and the Health Care Financing Administration on behalf of IDSA. He also helped organize the Managed Care in Infectious Diseases Conference in 1995. In 1996, IDSA honored him as its Clinician of the Year.
Dr. Tice has chaired the IDSA’s Quality Measures Task Force, was the State and Regional Societies representative to the Board of Directors, was a member of the IDSA OPAT Task Force, and served on the Quality Improvement Task Force. He also served as the Society’s delegate to the American Medical Association (AMA) House of Delegates and AMA’s Physician Consortium for Performance Network.
Dr. Tice, currently retired, was an associate professor at the John A. Burns School of Medicine, University of Hawaii. Prior to this position, Dr. Tice started an infectious diseases practice in Washington state. There he assembled a group of infectious diseases specialists who developed programs in outpatient parenteral antimicrobial therapy, clinical research, and infection control. He also developed an outpatient ID unit that included a travel clinic, a reference microbiology laboratory, and a tuberculosis clinic.
Dr. Tice founded the OutPatient IntraVenous Infusion Therapy Association (OPIVITA) and directed the organization’s Outcomes Registry. His scientific contributions include authoring countless articles and abstracts on subjects ranging from OPAT to urinary tract infections, new antibiotics, and managed care. In addition to OPAT, his areas of particular interest include outcomes measures, networking, managed care, viral hepatitis, staphylococci, and appropriate antibiotic use.
A graduate of Harvard College and Columbia College of Physicians and Surgeons, Dr. Tice trained in internal medicine at Roosevelt Hospital (New York) and New York University before completing a fellowship in infectious diseases under Louis Weinstein, MD, PhD, FIDSA at Tufts University’s New England Medical Center.
Dr. Tice was also a founder, then president, of the Infectious Diseases Society of Washington and started the Hepatitis Resource Network for ID specialists to develop programs to improve treatment for patients with viral hepatitis. He was editor of the OPAT Newsletter and a section editor for Infectious Diseases in Clinical Practice, ID Alert, ID News, Contagion, and other publications, and served on the editorial advisory board for Clinical Infectious Diseases. He has also constructed the IDLinks.com and OPAT.com web pages for ID specialists.
For his tireless energy in providing quality patient care, along with his countless hours of commitment to the Society, IDSA is proud to honor Dr. Tice with a 2012 Society Citation.
Carol J. Baker, MD, FIDSAWafaa El-Sadr, MD, MPH, MPA, FIDSA
John G. Bartlett, MD, FIDSATheodore C. Eickhoff, MD, FIDSA
Gary P. Wormser, MD, FIDSAEduardo Gotuzzo, MD, FIDSA
Larry J. Strausbaugh, MD, FIDSA
George G. Jackson, MDLawrence P. Martinelli, MD
Stanley Falkow, PhDWalter T. Hughes, Jr., MDEmanuel Wolinsky, MD
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America